CoChat

Regulation of the severity of neuroinflammation and demyelination by TLR‐ASK1‐p38 pathway

Open access
Guo, Xiaoli, Harada, Chikako, Namekata, Kazuhiko, Matsuzawa, Atsushi, Camps, Monsterrat, Ji, Hong, Swinnen, Dominique, Jorand‐Lebrun, Catherine, Muzerelle, Mathilde, Vitte, Pierre‐Alain, Rückle, Thomas, Kimura, Atsuko, Kohyama, Kuniko, Matsumoto, Yoh, Ichijo, Hidenori, Harada, Takayuki · 2010 · EMBO Molecular Medicine
Cited by 143

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Apoptosis signal-regulating kinase 1 (ASK1) is an evolutionarily conserved mitogen-activated protein kinase (MAPK) kinase kinase which plays important roles in stress and immune responses. Here, we show that ASK1 deficiency attenuates neuroinflammation in experimental autoimmune encephalomyelitis (EAE), without affecting the proliferation capability of T cells. Moreover, we found that EAE upregulates expression of Toll-like receptors (TLRs) in activated astrocytes and microglia, and that TLRs can synergize with ASK1-p38 MAPK signalling in the release of key chemokines from astrocytes. Consequently, oral treatment with a specific small molecular weight inhibitor of ASK1 suppressed EAE-induced autoimmune inflammation in both spinal cords and optic nerves. These results suggest that the TLR-ASK1-p38 pathway in glial cells may serve as a valid therapeutic target for autoimmune demyelinating disorders including multiple sclerosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/emmm.201000103

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 143

Metadata

Authors
Guo, X., Harada, C., Namekata, K., Matsuzawa, A., Camps, M., Ji, H., Swinnen, D., Jorand‐Lebrun, C., Muzerelle, M., Vitte, P., Rückle, T., Kimura, A., Kohyama, K., Matsumoto, Y., Ichijo, H., & Harada, T.
Venue
EMBO Molecular Medicine
Published
2010-11-10
Volume
2
Issue
12
Pages
504-515
ISSN
  • 1757-4676 (ISSN-L)
  • 1757-4684
OpenAlex
W1861665996
Cited by
143
References
8
FWCI
3.08
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.